Medis Product Portfolio
Showing 10 of 42 results
All Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a produc
Clear Filters
Abiraterone
- Status:
- Available
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 500mg
- Dosage Form:
- Film-Coated Tablet
- Availability:
- Available
Alectinib
- Status:
- Under Development
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 150mg
- Dosage Form:
- Capsule, Hard
- Availability:
- Under Development
Apalutamide
- Status:
- Under Development
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 60mg, 240mg
- Dosage Form:
- Film-Coated Tablet
- Availability:
- Under Development
Apremilast
- Status:
- Available
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 10mg, 20mg, 30mg
- Dosage Form:
- Film-Coated Tablet
- Availability:
- Available
Bortezomib
- Status:
- Available
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 3.5mg
- Dosage Form:
- Powder For Solution For Injection
- Availability:
- Available
Busulfan
- Status:
- Available with specific restrictions
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 6mg/ml
- Dosage Form:
- Concentrate For Solution For Infusion
- Availability:
- Available with specific restrictions
Cabazitaxel
- Status:
- Available
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 10mg/ml
- Dosage Form:
- Concentrate For Solution For Infusion
- Availability:
- Available
Cabozantinib
- Status:
- Available
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 20mg, 40mg, 60mg
- Dosage Form:
- Film-Coated Tablet
- Availability:
- Available
Clofarabine
- Status:
- Available with specific restrictions
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 1mg/ml (20mg/20ml)
- Dosage Form:
- Concentrate For Solution For Infusion
- Availability:
- Available with specific restrictions
Dabrafenib
- Status:
- Under Development
- Therapeutic Area:
- Antineoplastic and Immunomodulating Agents
- Dosage:
- 50mg, 75mg
- Dosage Form:
- Capsule, Hard
- Availability:
- Under Development